A higher discount rate indicates increased perceived risk or a higher cost of capital for the asset, which lowers its current valuation. A lower rate suggests reduced risk or improved confidence in the asset's future cash flow realization.
The discount rate applied to the projected future cash flows of the HLD-0915 asset to determine its present value. This...
Comparable to weighted average cost of capital (WACC) or risk-adjusted hurdle rates used by pharmaceutical peers for specific R&D pipeline assets.
jnj_segment_hld_0915_discount_rate| Q4 '25 | |
|---|---|
| Value | 0.2 |